Literature DB >> 33879157

Inhibition of MLKL-dependent necroptosis via downregulating interleukin-1R1 contributes to neuroprotection of hypoxic preconditioning in transient global cerebral ischemic rats.

Lixuan Zhan1, Xiaomei Lu1, Wensheng Xu1, Weiwen Sun1, En Xu2.   

Abstract

BACKGROUND: Our previous study indicated that hypoxic preconditioning reduced receptor interacting protein (RIP) 3-mediated necroptotic neuronal death in hippocampal CA1 of adult rats after transient global cerebral ischemia (tGCI). Although mixed lineage kinase domain-like (MLKL) has emerged as a crucial molecule for necroptosis induction downstream of RIP3, how MLKL executes necroptosis is not yet well understood. In this study, we aim to elucidate the molecular mechanism underlying hypoxic preconditioning that inactivates MLKL-dependent neuronal necroptosis after tGCI.
METHODS: Transient global cerebral ischemia was induced by the four-vessel occlusion method. Twenty-four hours before ischemia, rats were exposed to systemic hypoxia with 8% O2 for 30 min. Western blotting was used to detect the expression of MLKL and interleukin-1 type 1 receptor (IL-1R1) in CA1. Immunoprecipitation was used to assess the interactions among IL-1R1, RIP3, and phosphorylated MLKL (p-MLKL). The concentration of intracellular free calcium ion (Ca2+) was measured using Fluo-4 AM. Silencing and overexpression studies were used to study the role of p-MLKL in tGCI-induced neuronal death.
RESULTS: Hypoxic preconditioning decreased the phosphorylation of MLKL both in neurons and microglia of CA1 after tGCI. The knockdown of MLKL with siRNA decreased the expression of p-MLKL and exerted neuroprotective effects after tGCI, whereas treatment with lentiviral delivery of MLKL showed opposite results. Mechanistically, hypoxic preconditioning or MLKL siRNA attenuated the RIP3-p-MLKL interaction, reduced the plasma membrane translocation of p-MLKL, and blocked Ca2+ influx after tGCI. Furthermore, hypoxic preconditioning downregulated the expression of IL-1R1 in CA1 after tGCI. Additionally, neutralizing IL-1R1 with its antagonist disrupted the interaction between IL-1R1 and the necrosome, attenuated the expression and the plasma membrane translocation of p-MLKL, thus alleviating neuronal death after tGCI.
CONCLUSIONS: These data support that the inhibition of MLKL-dependent neuronal necroptosis through downregulating IL-1R1 contributes to neuroprotection of hypoxic preconditioning against tGCI.

Entities:  

Keywords:  Calcium ion influx; Cerebral ischemia; Hypoxic preconditioning; IL-1R1; MLKL; Necroptosis; Plasma membrane translocation

Year:  2021        PMID: 33879157     DOI: 10.1186/s12974-021-02141-y

Source DB:  PubMed          Journal:  J Neuroinflammation        ISSN: 1742-2094            Impact factor:   8.322


  41 in total

Review 1.  The Structural Basis of Necroptotic Cell Death Signaling.

Authors:  Emma J Petrie; Peter E Czabotar; James M Murphy
Journal:  Trends Biochem Sci       Date:  2018-11-30       Impact factor: 13.807

2.  Hypoxic preconditioning induces neuroprotection against transient global ischemia in adult rats via preserving the activity of Na(+)/K(+)-ATPase.

Authors:  Lixuan Zhan; Wenhong Peng; Weiwen Sun; En Xu
Journal:  Neurochem Int       Date:  2011-06-06       Impact factor: 3.921

3.  Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis.

Authors:  Zhenyu Cai; Siriporn Jitkaew; Jie Zhao; Hsueh-Cheng Chiang; Swati Choksi; Jie Liu; Yvona Ward; Ling-Gang Wu; Zheng-Gang Liu
Journal:  Nat Cell Biol       Date:  2013-12-08       Impact factor: 28.824

4.  Neuroprotection of hypoxic postconditioning against global cerebral ischemia through influencing posttranslational regulations of heat shock protein 27 in adult rats.

Authors:  Lixuan Zhan; Liu Liu; Kongping Li; Baoxing Wu; Dandan Liu; Donghai Liang; Haixia Wen; Yanmei Wang; Weiwen Sun; Weiping Liao; En Xu
Journal:  Brain Pathol       Date:  2017-02-15       Impact factor: 6.508

5.  Hypoxic preconditioning attenuates necroptotic neuronal death induced by global cerebral ischemia via Drp1-dependent signaling pathway mediated by CaMKIIα inactivation in adult rats.

Authors:  Lixuan Zhan; Zhiwei Lu; Xinyong Zhu; Wensheng Xu; Luxi Li; Xinyu Li; Siyuan Chen; Weiwen Sun; En Xu
Journal:  FASEB J       Date:  2018-08-27       Impact factor: 5.191

Review 6.  Necroptosis.

Authors:  Andreas Linkermann; Douglas R Green
Journal:  N Engl J Med       Date:  2014-01-30       Impact factor: 91.245

7.  Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death.

Authors:  Joanne M Hildebrand; Maria C Tanzer; Isabelle S Lucet; Samuel N Young; Sukhdeep K Spall; Pooja Sharma; Catia Pierotti; Jean-Marc Garnier; Renwick C J Dobson; Andrew I Webb; Anne Tripaydonis; Jeffrey J Babon; Mark D Mulcair; Martin J Scanlon; Warren S Alexander; Andrew F Wilks; Peter E Czabotar; Guillaume Lessene; James M Murphy; John Silke
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

Review 8.  Necroptosis in development and diseases.

Authors:  Bing Shan; Heling Pan; Ayaz Najafov; Junying Yuan
Journal:  Genes Dev       Date:  2018-03-01       Impact factor: 11.361

9.  Necrostatin-1 Prevents Necroptosis in Brains after Ischemic Stroke via Inhibition of RIPK1-Mediated RIPK3/MLKL Signaling.

Authors:  Xu-Xu Deng; Shan-Shan Li; Feng-Yan Sun
Journal:  Aging Dis       Date:  2019-08-01       Impact factor: 6.745

10.  Autophagosome maturation mediated by Rab7 contributes to neuroprotection of hypoxic preconditioning against global cerebral ischemia in rats.

Authors:  Lixuan Zhan; Siyuan Chen; Kongping Li; Donghai Liang; Xinyong Zhu; Liu Liu; Zhiwei Lu; Weiwen Sun; En Xu
Journal:  Cell Death Dis       Date:  2017-07-20       Impact factor: 8.469

View more
  1 in total

1.  Preconditioning With Intermittent Hypobaric Hypoxia Attenuates Stroke Damage and Modulates Endocytosis in Residual Neurons.

Authors:  Yaqi Wan; Lu Huang; Yanmin Liu; Weizhong Ji; Changxing Li; Ri-Li Ge
Journal:  Front Neurol       Date:  2021-12-15       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.